anti ki 67 antibody Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 80
    Abcam anti ki67 antibody
    Anti Ki67 Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 80/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ki67 antibody/product/Abcam
    Average 80 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti ki67 antibody - by Bioz Stars, 2022-11
    80/100 stars
      Buy from Supplier

    91
    Abcam anti ki67 antibody sp6
    TESC effectively promoted the proliferation, migration, invasion, and inhibited the apoptosis of PTMC. A The expression of TESC in PTMC tissues and PTMC-adjacent tissues was detected by IHC, and the expression change of TESC was statistically analyzed. B The mRNA expression of TESC in the cells was detected using qRT-PCR. C Three target RNAi sequences of TESC were cloned into GV493 vector, and then were transfected into TPC-1 and BHT101 cells using Polybrene, respectively. The interference efficiency was determined by qRT-PCR. D and E The effect of TESC on the proliferation of TPC-1 and BHT101 cells was detected by CCK8 and colony formation assay. F The apoptosis rate of TPC-1 and BHT101 cells was determined by flow cytometric assay. G The effect of TESC on the migration of TPC-1 and BHT101 cells was examined by scratch test. H The effect of TESC on the invasion abilities of TPC-1 and BHT101 cells was examined by transwell assay. I and J TESC-RNAi transfected (a total of 2 × 10 6 ) or control cells were subcutaneously injected into the flanks of nude mice. Tumor volume and weight were measured. K The level of <t>Ki-67</t> was detected by IHC after the inhibition of TESC. The means ± SD of three independent samples were shown. * p
    Anti Ki67 Antibody Sp6, supplied by Abcam, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ki67 antibody sp6/product/Abcam
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti ki67 antibody sp6 - by Bioz Stars, 2022-11
    91/100 stars
      Buy from Supplier

    ki67  (Abcam)
    99
    Abcam ki67
    Effects of the HSP 90 inhibitor 17 AAG diminish in 3D and cannot be aligned to the biomarker KRAS (A549/H441). Strong treatment responses regarding viability, proliferation, and apoptosis can be observed only in 2D conditions. (A) Cells cultured in 2D conditions were treated with different concentrations of the HSP 90 inhibitor 17 AAG . Viability was determined after 3 days of treatment by a CellTiter‐Glo ® Luminescent Cell Viability Assay. n ≥ 4. (B) 3D cultured cells were treated with 0.25 μ m 17 AAG , paraffin‐embedded, and HE ‐stained. Scale bar is 100 μm. (C) The proliferation rate in 2D and 3D was determined by counting <t>Ki67‐positive</t> cells from immunofluorescence staining in 10 images per sample. Total cell number was quantified by DAPI counterstaining. * P
    Ki67, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ki67/product/Abcam
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ki67 - by Bioz Stars, 2022-11
    99/100 stars
      Buy from Supplier

    99
    Abcam anti ki67
    Effects of the HSP 90 inhibitor 17 AAG diminish in 3D and cannot be aligned to the biomarker KRAS (A549/H441). Strong treatment responses regarding viability, proliferation, and apoptosis can be observed only in 2D conditions. (A) Cells cultured in 2D conditions were treated with different concentrations of the HSP 90 inhibitor 17 AAG . Viability was determined after 3 days of treatment by a CellTiter‐Glo ® Luminescent Cell Viability Assay. n ≥ 4. (B) 3D cultured cells were treated with 0.25 μ m 17 AAG , paraffin‐embedded, and HE ‐stained. Scale bar is 100 μm. (C) The proliferation rate in 2D and 3D was determined by counting <t>Ki67‐positive</t> cells from immunofluorescence staining in 10 images per sample. Total cell number was quantified by DAPI counterstaining. * P
    Anti Ki67, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ki67/product/Abcam
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti ki67 - by Bioz Stars, 2022-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    TESC effectively promoted the proliferation, migration, invasion, and inhibited the apoptosis of PTMC. A The expression of TESC in PTMC tissues and PTMC-adjacent tissues was detected by IHC, and the expression change of TESC was statistically analyzed. B The mRNA expression of TESC in the cells was detected using qRT-PCR. C Three target RNAi sequences of TESC were cloned into GV493 vector, and then were transfected into TPC-1 and BHT101 cells using Polybrene, respectively. The interference efficiency was determined by qRT-PCR. D and E The effect of TESC on the proliferation of TPC-1 and BHT101 cells was detected by CCK8 and colony formation assay. F The apoptosis rate of TPC-1 and BHT101 cells was determined by flow cytometric assay. G The effect of TESC on the migration of TPC-1 and BHT101 cells was examined by scratch test. H The effect of TESC on the invasion abilities of TPC-1 and BHT101 cells was examined by transwell assay. I and J TESC-RNAi transfected (a total of 2 × 10 6 ) or control cells were subcutaneously injected into the flanks of nude mice. Tumor volume and weight were measured. K The level of Ki-67 was detected by IHC after the inhibition of TESC. The means ± SD of three independent samples were shown. * p

    Journal: BMC Cancer

    Article Title: Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway

    doi: 10.1186/s12885-022-09643-9

    Figure Lengend Snippet: TESC effectively promoted the proliferation, migration, invasion, and inhibited the apoptosis of PTMC. A The expression of TESC in PTMC tissues and PTMC-adjacent tissues was detected by IHC, and the expression change of TESC was statistically analyzed. B The mRNA expression of TESC in the cells was detected using qRT-PCR. C Three target RNAi sequences of TESC were cloned into GV493 vector, and then were transfected into TPC-1 and BHT101 cells using Polybrene, respectively. The interference efficiency was determined by qRT-PCR. D and E The effect of TESC on the proliferation of TPC-1 and BHT101 cells was detected by CCK8 and colony formation assay. F The apoptosis rate of TPC-1 and BHT101 cells was determined by flow cytometric assay. G The effect of TESC on the migration of TPC-1 and BHT101 cells was examined by scratch test. H The effect of TESC on the invasion abilities of TPC-1 and BHT101 cells was examined by transwell assay. I and J TESC-RNAi transfected (a total of 2 × 10 6 ) or control cells were subcutaneously injected into the flanks of nude mice. Tumor volume and weight were measured. K The level of Ki-67 was detected by IHC after the inhibition of TESC. The means ± SD of three independent samples were shown. * p

    Article Snippet: Then, paraffin sections (5 μm) were analyzed by IHC with anti-Ki-67 antibody (1:200, cat. no. ab16667, abcam, USA).

    Techniques: Migration, Expressing, Immunohistochemistry, Quantitative RT-PCR, Clone Assay, Plasmid Preparation, Transfection, Colony Assay, Flow Cytometry, Transwell Assay, Injection, Mouse Assay, Inhibition

    Effects of the HSP 90 inhibitor 17 AAG diminish in 3D and cannot be aligned to the biomarker KRAS (A549/H441). Strong treatment responses regarding viability, proliferation, and apoptosis can be observed only in 2D conditions. (A) Cells cultured in 2D conditions were treated with different concentrations of the HSP 90 inhibitor 17 AAG . Viability was determined after 3 days of treatment by a CellTiter‐Glo ® Luminescent Cell Viability Assay. n ≥ 4. (B) 3D cultured cells were treated with 0.25 μ m 17 AAG , paraffin‐embedded, and HE ‐stained. Scale bar is 100 μm. (C) The proliferation rate in 2D and 3D was determined by counting Ki67‐positive cells from immunofluorescence staining in 10 images per sample. Total cell number was quantified by DAPI counterstaining. * P

    Journal: Molecular Oncology

    Article Title: A combined tissue‐engineered/in silico signature tool patient stratification in lung cancer

    doi: 10.1002/1878-0261.12323

    Figure Lengend Snippet: Effects of the HSP 90 inhibitor 17 AAG diminish in 3D and cannot be aligned to the biomarker KRAS (A549/H441). Strong treatment responses regarding viability, proliferation, and apoptosis can be observed only in 2D conditions. (A) Cells cultured in 2D conditions were treated with different concentrations of the HSP 90 inhibitor 17 AAG . Viability was determined after 3 days of treatment by a CellTiter‐Glo ® Luminescent Cell Viability Assay. n ≥ 4. (B) 3D cultured cells were treated with 0.25 μ m 17 AAG , paraffin‐embedded, and HE ‐stained. Scale bar is 100 μm. (C) The proliferation rate in 2D and 3D was determined by counting Ki67‐positive cells from immunofluorescence staining in 10 images per sample. Total cell number was quantified by DAPI counterstaining. * P

    Article Snippet: The primary antibodies E‐cadherin (#610181; BD Transduction Laboratories, Heidelberg, Germany), β‐catenin (#ab32572; Abcam, Cambridge, UK), and Ki67 (#ab16667; Abcam) were diluted 1 : 100 and incubated overnight at 4 °C.

    Techniques: Biomarker Assay, Cell Culture, Cell Viability Assay, Staining, Immunofluorescence

    Biomarker‐dependent response upon EGFR inhibition is improved in 3D and can also be simulated in silico . (A) Cells cultured in 3D that were either treated with 1 μ m Gef or used as untreated controls were paraffin‐embedded and HE ‐stained. Scale bar is 100 μm. (B) The proliferation rate (proliferative cells per total cell number) was determined by counting Ki67‐positive cells from immunofluorescence staining in 10 images per sample. Total cell number was quantified by DAPI counterstaining. *** P

    Journal: Molecular Oncology

    Article Title: A combined tissue‐engineered/in silico signature tool patient stratification in lung cancer

    doi: 10.1002/1878-0261.12323

    Figure Lengend Snippet: Biomarker‐dependent response upon EGFR inhibition is improved in 3D and can also be simulated in silico . (A) Cells cultured in 3D that were either treated with 1 μ m Gef or used as untreated controls were paraffin‐embedded and HE ‐stained. Scale bar is 100 μm. (B) The proliferation rate (proliferative cells per total cell number) was determined by counting Ki67‐positive cells from immunofluorescence staining in 10 images per sample. Total cell number was quantified by DAPI counterstaining. *** P

    Article Snippet: The primary antibodies E‐cadherin (#610181; BD Transduction Laboratories, Heidelberg, Germany), β‐catenin (#ab32572; Abcam, Cambridge, UK), and Ki67 (#ab16667; Abcam) were diluted 1 : 100 and incubated overnight at 4 °C.

    Techniques: Biomarker Assay, Inhibition, In Silico, Cell Culture, Staining, Immunofluorescence

    Improved reflection of tumor characteristics by the 3D tissue‐engineered lung tumor model. Tested tumor cell line populations display more homogeneous marker expression in 3D as well as reduced proliferation correlating to tumors. (A) Cells cultured in 2D and 3D conditions shown with immunofluorescence by double stain for E‐cadherin and β‐catenin. Green arrows indicate positive cells and white arrows negative. Scale bars are 50 μm. (B) Paraffin‐embedded adenocarcinoma from patient biopsy was immunofluorescence‐double‐stained against E‐cadherin and β‐catenin. Scale bar is 100 μm. (C) The expression of the proliferation marker Ki67 was detected by immunofluorescence staining of 2D and 3D cultured HCC 827 cells, as well as in vivo tissue from a patient biopsy. Scale bar is 100 μm.

    Journal: Molecular Oncology

    Article Title: A combined tissue‐engineered/in silico signature tool patient stratification in lung cancer

    doi: 10.1002/1878-0261.12323

    Figure Lengend Snippet: Improved reflection of tumor characteristics by the 3D tissue‐engineered lung tumor model. Tested tumor cell line populations display more homogeneous marker expression in 3D as well as reduced proliferation correlating to tumors. (A) Cells cultured in 2D and 3D conditions shown with immunofluorescence by double stain for E‐cadherin and β‐catenin. Green arrows indicate positive cells and white arrows negative. Scale bars are 50 μm. (B) Paraffin‐embedded adenocarcinoma from patient biopsy was immunofluorescence‐double‐stained against E‐cadherin and β‐catenin. Scale bar is 100 μm. (C) The expression of the proliferation marker Ki67 was detected by immunofluorescence staining of 2D and 3D cultured HCC 827 cells, as well as in vivo tissue from a patient biopsy. Scale bar is 100 μm.

    Article Snippet: The primary antibodies E‐cadherin (#610181; BD Transduction Laboratories, Heidelberg, Germany), β‐catenin (#ab32572; Abcam, Cambridge, UK), and Ki67 (#ab16667; Abcam) were diluted 1 : 100 and incubated overnight at 4 °C.

    Techniques: Marker, Expressing, Cell Culture, Immunofluorescence, Staining, In Vivo